好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Unilateral Relapsing PACNS: an entity suggesting different immune response between the cerebral hemispheres
Autoimmune Neurology
Autoimmune Neurology Posters (7:00 AM-5:00 PM)
042

To determine whether studying patients with strictly unilateral relapsing primary angiitis of the central nervous system (UR-PACNS) can support hemispheric differences in immune response mechanisms, we reviewed characteristics of a group of such patients.  

UR-PACNS is rarely described. This disease subtype may hold clues to some immunological properties of the brain.

We surveilled our institution for UR-PACNS patients. We defined UR-PACNS as biopsy-proven PACNS relapsing strictly in one brain hemisphere three or more times, with or without hemi-atrophy. Three total cases were identified at our institution. A literature search for similar cases yielded four additional cases. The combined 7 cases were reviewed for demographic, clinical, imaging and pathological trends.  

The median age at time of clinical onset among the 7 cases was 26 years [range 10-49 years]; 5 were male (71%). All seven patients presented with seizures. The mean follow-up duration was 7.5 years [4-14.1 years]. The annual relapse rate ranged between 0.2 and 1. UR-PACNS involved the left cerebral hemisphere in 5 of the 7 patients. There was no consistent relationship between the patient’s dominant hand and the diseased side. When performed (5 cases), conventional angiogram was non-diagnostic. Cerebrospinal fluid examination showed nucleated cells and protein levels in normal range in 3 cases, and ranged from 6 to 11cells/µL and 49 to 110mg/dL in 4 cases. All cases were diagnosed with lesional biopsy, showing lymphocytic type of vasculitis of the small and medium-sized vessels. Patients treated with steroids alone showed progression.

We hypothesize that a functional difference in immune responses; caused by such discrepancies as basal levels of cytokines, asymmetric distribution of microglia, and differences in modulation of the systemic immune functions; rather than a structural antigenic difference, between the right and left brain may explain this phenomenon, but this is speculative.

Authors/Disclosures
Mahmoud A. AbdelRazek, MD (Wake Forest U / Atrium Neuroscience Institute)
PRESENTER
Dr. AbdelRazek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. AbdelRazek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. AbdelRazek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG therapeutics.
James M. Hillis, MD (Massachusetts General Hospital) Dr. Hillis has stock in Elly Health. The institution of Dr. Hillis has received research support from GE Healthcare. The institution of Dr. Hillis has received research support from Annalise.ai. The institution of Dr. Hillis has received research support from Viz.ai. The institution of Dr. Hillis has received research support from Cerebriu. The institution of Dr. Hillis has received research support from Heuron. The institution of Dr. Hillis has received research support from JLK Group. Dr. Hillis has received intellectual property interests from a discovery or technology relating to health care.
Yanjun Guo, MD (Massachusetts General Hospital) No disclosure on file
Maria Martinez-Lage, MD (Massachusetts General Hospital) The institution of Dr. Martinez-Lage has received research support from NIH.
Taha Gholipour, MD (UC San Diego Health - Comprehensive Epilepsy Center) Dr. Gholipour has nothing to disclose.
Jacob A. Sloane, MD, PhD (Beth Israel Deaconess Medical Center) Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for biogen. Dr. Sloane has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sloane has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
Tracey Cho, MD, FAAN Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of an immediate family member of Dr. Cho has received research support from NIH. Dr. Cho has received publishing royalties from a publication relating to health care.
Marcelo Matiello, MD, FAAN (Massachusetts General Hospital, Brigham, Harvard) Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Matiello has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WoltersKluwer.